Annual Congress Vienna 2009

---

---

PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?

Postgraduate Course
Chairs: T. Verheij (Utrecht, Netherlands), F. Blasi (Milan, Italy)
Aims: The main target of this course is to update participants on the current advances in knowledge regarding the vaccination and preventive measures for LRTIs. At the end of this course, participants will be able to: understand the correct methodological approach to the prophylaxis; understand the advantages of the new approaches in the prevention of respiratory infections in special populations; and understand the open questions for reseacrh in this field.

HERMES syllabus links: B.1.3: Chronic bronchitis, B.1.4: COPD; B.3: Non-TB respiratory infections.
Type of course: Lecture based
Level: Basic to intermediate

What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? R. Cosentini (Milan, Italy)
Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs? T. Verheij (Utrecht, Netherlands)
Does the treatment with inhaled steroids or long acting β-2-agonists prevent LRTIs? W. Wedzicha (London, United Kingdom)
Does regular physiotherapy prevent LRTIs in patients with chronic lung disease? P. Agent (London, United Kingdom)
Is there a place for oral mucolytics in the prevention of LRTI? - PRO L. Allegra (Milano, Italy)
Is there a place for oral mucolytics in the prevention of LRTI? - CON M. Miravitlles (Barcelona, Spain)
Should pneumococcal vaccines be used to prevent LRTI? E. Hak (Groningen, Netherlands)
Influenza vaccination and its relation with LRTI A. Ortqvist (Stockholm, Sweden)